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Abstract 17 
Hepatocytes are the preparation of choice for toxicological research in vitro.  However, 18 
despite the fact that hepatocytes proliferate in vivo during liver regeneration, they are resistant 19 
to proliferation in vitro, do not tolerate sub-culture and tend to enter a de-differentiation 20 
program that results in a loss of hepatic function.  These limitations have resulted in the 21 
search for expandable rodent and human cells capable of being directed to differentiate into 22 
functional hepatocytes.  Research with stem cells suggests that it may be possible to provide 23 
the research community with hepatocytes in vitro although to date, significant challenges 24 
remain, notably generating a sufficiently pure population of hepatocytes with a quantitative 25 
functionality comparable with hepatocytes.  This paper reviews work with the AR42J-B-13 26 
(B-13) cell line.  The B-13 cell was cloned from the rodent AR42J pancreatic cell line, 27 
express genes associated with pancreatic acinar cells and readily proliferates in simple culture 28 
media.  When exposed to glucocorticoid, 75-85% of the cells trans-differentiate into 29 
hepatocytes-like (B-13/H) cells functioning at a level quantitatively similar to freshly isolated 30 
rat hepatocytes (with the remaining cells retaining the B-13 phenotype).   Trans-31 
differentiation of pancreatic acinar cells also appears to occur in vivo in rats treated with 32 
glucocorticoid; in mice with elevated circulating glucocorticoid and in humans treated for 33 
long periods with glucocorticoid.  The B-13 response to glucocorticoid therefore appears to 34 
be related to a real pathophysiological response of a pancreatic cell to glucocorticoid.  An 35 
understanding of how this process occurs and if it can be generated or engineered in human 36 
cells would result in a cell line with the ability to generate an unlimited supply of functional 37 
human hepatocytes in a cost effective manner. 38 
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49 
1. Commonly used intact liver preparations in Toxicological research. 50 
The liver has long been the organ of choice for studying biochemistry because it is a large 51 
organ (providing sufficient material for experiments) and performs many of the metabolic 52 
reactions seen in animal cells.  Metabolism is a pivotal component in the toxic mechanisms of 53 
many xenobiotics (Wallace et al., 2008).  Therefore, liver preparations are often used to 54 
examine the toxicity of xenobiotics because the metabolic component of the mechanism is 55 
also present.  Thus, in addition to simply examining the metabolism of xenobiotics by the 56 
liver, subsequent effects on cell viability using intact preparations can be incorporated (Greer 57 
et al., 2010) as well as a range of more specific endpoints (e.g. DNA mutation by measuring 58 
the levels of unscheduled DNA synthesis (Madle et al., 1994; Li et al., 2008). 59 
A variety of in vitro intact liver preparations are used in experimental toxicology research 60 
(see Table 1), contributing to a reduction in the use of live animals for Toxicological 61 
research.  From whole liver perfusion to cell culture models, the preparations offer decreasing 62 
levels of hepatic functionality but increasing levels of experimental control.  These factors 63 
become important considerations when applied to scarce human preparations. 64 
 65 
2. Approaches to promoting hepatocyte phenotype in vitro. 66 
Cultured hepatocytes remain the most commonly used liver preparation used in Toxicological 67 
research at present, perhaps because it offers the most flexibility in terms of liver function 68 
and experimental control.  Collagenase perfusion of the liver is almost universally employed 69 
in hepatocyte isolation because it is a relatively simple and repeatable procedure.  It should be 70 
borne in mind however, that the procedure exerts considerable stress upon the cells, not least 71 
because the cells are exposed to a bacterial extract containing numerous inflammatory factor 72 
such as endotoxin (Rodriguez-Ariza and Paine, 1999; Paine and Andreakos, 2004).  The 73 
process as a whole also exposes the cells to oxidative stress (Rodriguez-Ariza and Paine, 74 
1999), which may be responsible for the initial siRNA-like re-programming and 75 
transcriptional silencing that occurs during and after isolation (Padgham and Paine, 1992; 76 
Padgham et al., 1993) and likely initiates de-differentiation (Wang et al., 1997; Hodgkinson 77 
et al., 2000).   78 
Expression of CYP450s in cultured liver preparations has often been used as a stringent test 79 
of hepatocyte differentiation status, perhaps because it is rapidly lost in hepatocytes cultured 80 
on plastic or collagen type-I-coated plates (Paine, 1990).  However, expression of some 81 
constitutive rodent CYP450s are dependent on cyclical changes in growth hormone levels in 82 
vivo, which are most variable in the male (Waxman and Holloway, 2009).  To what extent 83 
this may be the case in humans has not been intensively investigated although it may in part 84 
explain higher levels of the major liver drug metabolising CYP3A4 in females versus males 85 
(Cheung et al., 2006).  Since cyclical changes in hormone regulators are not easily replicated 86 
in vitro (and to our knowledge, no attempt has been made to do so), it may not be surprising 87 
that constitutive levels of expression of  some CYP450s (and potentially other liver-specific 88 
gene expression) are not retained in vitro. Response to CYP450 inducers may therefore be a 89 
more useful test of hepatocyte functionality. 90 
A variety of protocols have been examined in an attempt to prevent hepatocyte de-91 
differentiation, including co-culture of hepatocytes with other cell types or the use of specific 92 
culture media (e.g. Chee’s media) or media supplements (e.g. metyrapone) – for summary see 93 
Table 2.  The modifications that have the most impact on maintaining (or re-inducing) 94 
hepatocyte differentiation in vitro are those that use complex extracellular matrices (such as 95 
matrigel) and/or create a sandwich layer of extracellular proteins wherein hepatocytes are 96 
seeded onto proteins and a layer of protein is applied once the cells have attached (Schuetz et 97 
al., 1988; Schuetz et al., 1990; Sidhu et al., 1993; Kocarek et al., 1993; Nakajima and 98 
Shimbara, 1996; George et al., 1997; Hamilton et al., 2001; Richert et al., 2002).   Despite 99 
their effectiveness, complex extracellular matrices and/or sandwich layer configurations may 100 
still only slow the de-differentiation of hepatocytes in vitro, limiting the maximum length of 101 
experiments to less than a few weeks.  Hepatocytes also remain resistant to proliferation, 102 
despite undergoing DNA synthesis in response to mitogens such as EGF and HGF, and 103 
therefore cannot be expanded to any significant extent in vitro (Ajioka et al., 2002) although 104 
some interventions show promise (Kanki et al., 2009).  At present, the source for more 105 
hepatocytes therefore relies on animal or human donors. 106 
 107 
3. The pancreas and the history of the AR42J B-13 cell line  108 
The pancreas consists of two major tissue types, exocrine tissue consisting primarily of acinar 109 
cells and endocrine tissue consisting of islet cells (Figure 1).  The acinar tissue forms the bulk 110 
of the organ and functions to secrete digestive enzymes into the gut.  Islets, which make up 111 
only 4% of the adult rat pancreas (Githens, 1988), contain several cell types which secrete 112 
hormones into the blood stream, including the β cell which secretes insulin (see Table 3).   113 
The AR42J cell line is a widely used rat pancreatic acinar cancer (adenocarcinoma) cell line 114 
with an adherent epithelial morphology.   It was generated by administering azaserine to the 115 
inbred Wistar/Lewis rats in 1979 (Longnecker et al., 1979).  The pancreatic 116 
adenomacarcinomas generated by these studies were minced and then transplanted back into 117 
untreated rats of the same strain.  In 2 out of 12 attempts, transplantable tumour was 118 
generated and these were subsequently re-transplanted into naïve rats up to 5 times.   119 
Tumours from these rats were seeded into culture vessels in 1980 at the American Type 120 
Culture Collection (ATCC) in Rockville (Jessop and Hay, 1980).  One line expressed high 121 
levels of amylase and other exocrine enzymes (the AR42J) and remains both available from 122 
the ATCC and a frequently used model cell line in research today (Guo et al., 2010; Sebai et 123 
al., 2010; Szmola et al., 2010) 124 
The AR42J-B-13 cell line (henceforth referred to as the B-13 cell line) was cloned from the 125 
AR42J cell line by the Kojima lab in 1996 (Mashima et al., 1996).  Using the parent AR42J 126 
cell line, this group demonstrated that some of the cells converted into insulin-producing cells 127 
in vitro after treatment with activin A and betacellulin (Mashima et al., 1996).  Hepatocyte 128 
growth factor (HGF) had a similar effect and in the B-13 clone, most of the cells became 129 
insulin-producing cells.  More recently, this effect has been shown to require expression of 130 
transcription factor Ngn3 together with Nkx6.1 or MafA in B-13 cells (Ogihara et al., 2008). 131 
 132 
4. Trans-differentiation of the B-13 cell into a functional hepatocyte (B-13/H). 133 
The first observation that B-13 cells are able to differentiate into hepatocytes was made by 134 
the Tosh lab in 2000 (Shen et al., 2000).   When B-13 cells were treated with dexamethasone, 135 
they altered their phenotype [to B-13/H cells] (see Figure 2) and expressed a range of 136 
hepatocyte markers, including albumin, transferrin, and transthyretin suggestive of a 137 
qualitative change to an hepatocyte-like phenotype.  Expression of C/EBPβ in the cells 138 
provoked a similar change in the cells with a dominant-negative form of C/EBPβ inhibiting 139 
the dexamethasone-dependent process.  Examination of cytochrome P450 levels showed that 140 
the B-13 cells expressed hepatocyte levels of these genes with corresponding hepatocyte 141 
levels of function in many cases (Marek et al., 2003).  The B-13 cells therefore show promise 142 
as a progenitor for functional hepatocytes.  Exposure to glucocorticoid results in an apparent 143 
“trans-differentiation” of the cells since double staining showed that cells expressing liver 144 
markers primarily did not express amylase although faint co-expression was seen in some 145 
cells (Shen et al., 2000) and the B-13 cells do not appear to change to an altered plastic state 146 
prior to any change (see Figure 3).  Trans-differentiation is often defined as a type of 147 
metaplasia, where metaplasia is defined as the aberrant differentiation of a (stem or) 148 
progenitor cell to produce an alternative differentiation state to that expected (such as an 149 
hepatocyte in the pancreas) (Slack, 2007).  This is often observed in disease states where 150 
injury results in an inflammatory and altered extracellular environment (Slack, 2007).  151 
Placing rats on a copper-deficient diet or by administering cadmium results in extensive 152 
pancreatic damage and the apparent appearance of “hepatocytes” in the pancreas (Rao et al., 153 
1988; Yeldandi, et al., 1990; Konishi et al., 1990; Waalkes et al., 1992), although technically, 154 
the detection of liver-specific albumin gene expression alone is minimal evidence for the 155 
phenomenon.  Similar observations have also been reported when some growth factors are 156 
over-expressed in the pancreas (Krakowski et al., 1999; Yamaoka et al., 2002).  These 157 
responses in the pancreas were considered to be metaplastic responses (Makino et al., 1990; 158 
Dabeva et al., 1997).  If the B-13 cell were analogous (or equivalent) to a pancreatic 159 
progenitor cell, then the differentiation of B-13 cells into hepatocytes might be defined as a 160 
metaplastic response to glucocorticoid.  However, if acinar cells were directed to differentiate 161 
into hepatocytes in response to glucocorticoid, then the response would be trans-162 
differentiation and therefore likely unrelated to the metaplasia that occurs in response to 163 
copper depletion or over-expression of growth factors.  The latter is supported by the 164 
observation that the isolation and culture of pancreatic acinar cells and exposure to 165 
glucocorticoid results in the expression of genes expressed in hepatocytes (Shen et al., 2000) 166 
although culture in vitro may induce a degree of plasticity (Lardon et al., 2004), in which 167 
case the mechanism could in theory be metaplasia.  The best evidence that B-13 cells undergo 168 
trans-differentiation in vitro in response to glucocorticoid is the observation that green 169 
fluorescent protein expression driven from an elastase promoter (which is active in pancreatic 170 
acinar cells) remains detectable in B-13/H cells (Shen et al., 2000), suggesting B-13/H cells 171 
are derived from the B-13 cells (or cells that trans-activate the elastase promoter). 172 
We have attempted to determine whether glucocorticoid exposure in vivo results in the 173 
appearance of hepatocytes in the pancreas of adult rodents and humans.  To test this 174 
hypothesis, adult rats were initially treated for 25 days with glucocorticoid.  Examination of 175 
the pancreas and immunohistochemical analyses demonstrated that glucocorticoid treatment 176 
resulted in the appearance of pancreatic acinar cells expressing hepatocyte markers such as 177 
CYP2E (Wallace et al., 2009) or CPS (Figure 4).  Expression was normally localised to a 178 
single cell or small group of cells, suggesting that cells had trans-differentiated or partially 179 
trans-differentiated into hepatocyte-like cells.  However, the appearance of such cells was 180 
rare although significantly higher than background levels determined in control vehicle-181 
treated rats (Wallace et al., 2009).  The low numbers of pancreatic hepatocytes meant that it 182 
was not possible to screen for liver markers in a more rigourous and quantitative fashion and 183 
therefore there remained the potential that this was simply a rare and fairly insignificant 184 
phenomenon.  To further test the hypothesis, a transgenic mouse [Tg(Crh)] that over-185 
expressed the rat corticotrophin releasing hormone under control of the mouse metalothienin-186 
I promoter (Stenzel-Poore et al., 1992) was examined (Wallace et al., 2010a), see Figure 5.  187 
These mice have high circulating endogenous glucocorticoid (Figure 5).  Both female and 188 
male transgenic mice are viable although female mice are either infertile or unable to carry 189 
litters to term.  Male Tg(Crh) mice were therefore crossed with wild type (w/t) female mice 190 
to generate the colony.  Adult Tg(Crh) mice showed the classic symptoms of Cushing’s 191 
syndrome with increasing age including obesity, hair loss, insulin resistance, thymic and 192 
splenic atropy and thinning skin (Figure 6).  At 21 weeks of age, pancreata from w/t and 193 
Tg(Crh) mice were examined and the expression of liver markers determined.  At this stage, 194 
pancreata from Tg(Crh) mice were significantly smaller than pancreata from w/t mice, 195 
despite islet hyperplasia and higher specific levels of insulin in Tg(Crh) pancreata (Wallace et 196 
al., 2010a), likely associated with obesity and the development of insulin resistance in 197 
Tg(Crh) mice (Wallace et al., 2010).  Extensive areas of the Tg(Crh) acinar pancreas stained 198 
positive for liver markers such as CYP2E and this was confirmed by RT-PCR (for CYP2E, 199 
albumin, CPS and other liver markers – see also Figure 6) and by Western blotting, whereas 200 
expression of these genes was not detected in pancreata from w/t mice (Wallace et al., 201 
2010a).  A quantitatively similar level of expression of hepatocyte expression was observed 202 
in Tg(Crh) pancreata (Figure 6).  Indeed, in ageing animals the effects of this process exert 203 
their physiological effects in that a significant proportion of Tg(Crh) mice begin to suffer 204 
from malabsorption, alleviated by supplementing their diet with porcine pancreatic enzyme 205 
supplements (Wallace et al., 2010a).  Critically, these studies demonstrate that chronic 206 
elevated glucocorticoid exposure results in widespread expression of hepatocyte marker gene 207 
expression in the pancreas and that glucocorticoid alone (there was no evidence for 208 
pancreatic damage in the Tg(Crh) pancreata) can result in either metaplasia of a pancreatic 209 
progenitor and/or trans-differentiation of a mature acinar cell into an hepatocyte in vivo.  The 210 
B-13 cell response in vitro therefore appears to be a real pathophysiological response of the 211 
pancreas to elevated glucocorticoid. 212 
Whilst observing the effects of chronic elevated endogenous glucocorticoid on the mouse 213 
pancreas, continuing studies on the mechanism of B-13 cell trans-differentiation have been 214 
made.  It is known that over-expression of the transcription factor C/EBP-β in B-13 cells 215 
drives the trans-differentiation to B-13/H cells (Shen et al., 2000), suggesting that C/EBP-β is 216 
a critical mediator in the process of trans-differentiation.  In view of the role of the 217 
glucocorticoid receptor in the process and that nuclear receptors are known to cross talk with 218 
the WNT signalling pathway (Figure 7), the role of WNT signalling in trans-differentiation 219 
has been examined.  WNT3a is known to be involved in hepatic development and this protein 220 
is expressed by B-13 cells (Wallace et al., 2009, Wallace et al., 2010b).  However, 221 
glucocorticoid exposure resulted in a transient repression of WNT3a expression in B-13 cells 222 
around the time of maximal trans-differentiation into B-13/H cells (Wallace et al., 2010b).  223 
At this time, there was increasing levels of β-catenin phosphorylation, reductions in cellular 224 
β-catenin levels and an absence in localisation within the nucleus (Wallace et al., 2010b).  225 
These changes resulted in a repression in distal WNT-dependent Tcf/Lef transcriptional 226 
activity (Wallace et al., 2010b).  These observations are all commensurate with a repression 227 
in canonical WNT signalling activity in B-13 cell trans-differentiation.  A small molecule 228 
WNT agonist or over-expression of a non-degradable β-catenin protein blocked 229 
glucocorticoid-dependent trans-differentiation (Wallace et al., 2010b).  Si RNA knockdown 230 
of β-catenin expression substituted for glucocorticoid on B-13 trans-differentiation (Wallace 231 
et al., 2010b).  These data indicate that suppression of WNT signalling regulates B-13 trans-232 
differentiation and examination of C/EBP-β expression in these studies indicate that it occurs 233 
upstream of C/EBP-β induction (Wallace et al., 2010b).  Translating these observations to the 234 
response to elevated glucocorticoid in vivo, β-catenin is localised to the acinar cell membrane 235 
in the pancreas of w/t mice whereas regions of the acinar pancreas in Tg(Crh) mice show a 236 
more dispersed localisation of β-catenin (Figure 8), suggesting changes in WNT signalling 237 
may also occur in vivo as part of the trans-differentiation process. 238 
 239 
5. Summary. 240 
Glucocorticoids are potent hormones and are often employed in stem cell differentiation 241 
protocols, although their use is likely based on emperical observations that inclusion 242 
improves the maturation of cells to a differentiated phenotype.  There is a rationale basis for 243 
their use however, since placental enzymes protect the developing foetus from maternal 244 
glucocorticoid exposure.  Foetal tissues are exposed to glucocorticoids as the the foetal HPA 245 
axis develops and likely the glucocorticoid plays a role in later tissue development.  Indeed, 246 
glucocorticoid is often administered to premature babies to promote lung maturation and 247 
function.  The observations made with glucocorticoid and pancreatic trans-differentiation are 248 
therefore likely to be related to a normal physiological response of cells within the pancreas 249 
to glucocorticoid, or at least a pathophysiological response to glucocorticoid.  If we can 250 
dissect the mechanism(s) by which B-13 cells readily proliferate in a stable manner and trans-251 
differentiate into functional hepatocytes in vitro under such simple conditions, then we may 252 
be able to engineer a human equivalent and fulfill a long time goal to generate an unlimited 253 
supply of human hepatocytes for Toxicology and numerous other fields. 254 
 255 
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Figure legends 571 
 572 
Fig. 1.   Histology of the pancreas.  Rat pancreas was fixed and stained (left panels) for 573 
amylase (acinar marker) or insulin (islet β cell marker) as outlined in Wallace et al., (2010a), 574 
and visualised with DAB (brown) followed by haematoxylin.  Right panel, acinar tissue 575 
stained with haematoxylin and eosin as outlined (Wallace et al., 2010a). 576 
 577 
578 
 579 
Fig. 2.  Phenotype of B-13 and B-13H cells in vitro.  A, light microscopy of B-13 cells and 580 
B-13H cells after trans-differentiation with dexamethasone for 14 days as outlined in Wallace 581 
et al. (2010b).  Cells fixed and stained with haematoxylin and eosin. 582 
 583 
584 
 585 
Fig. 3.  Metaplasia and trans-differentiation.  A, schematic diagram of metaplasia and trans-586 
differentiation from a progenitor cell (pc) into either cell type A or B via intermediates a and 587 
b respectively.  B, comparing metaplasia with trans-differentiation. 588 
 589 
590 
 591 
Fig. 4.  Appearance of hepatocyte-like cells satining positive for  carbamoyl phosphate 592 
synthase I (CPS) in rat pancreas after exposure to elevated levels of glucocorticoid.  Male 593 
Sprague-Dawley rats (150-175g body weight) were administered 10mg dexamethasone-21-594 
phosphate (Dex-21-P) / kg body weight from a 5mg / ml PBS stock by i.p. injection up to 3 595 
times per week as outlined in Wallace et al. (2009).  Control rats received PBS vehicle (2mls 596 
/ kg body weight) by i.p. injection.  After 25 days, the liver and pancreata were examined for 597 
the expression of CPS by immunohistochemistry as outlined Wallace et al., (2010a).  No 1o 598 
control, sections stained identically except for primary anti-CPS antibody incubation.  Note, 599 
CPS (also previously referred to as Hep Par I) is a specifically normally only expressed in the 600 
liver (Butler et al., 2008). 601 
 602 
603 
 604 
 605 
Fig. 5.  The C57Bl6 Tg(Crh) mouse.  A, schematic diagram of the hypothalamic pituitary 606 
axis (HPA) and the normal regulation of endogenous glucocorticoid levels and comparison to 607 
the Tg(Crh) transgene (Stenzel-Poore et al., 1992).  B, Identification of transgenic mice by 608 
PCR (Walace et al., 2010a).  C, circulating corticosteroid levels in C57Bl6 w/t and C57Bl6 609 
Tg(Crh) mice by ELISA according to the manufacturer’s instructions (Diagnostic Systems 610 
Laboratories - DSL-10-81100, Beckmann Coulter, High Wycombe, UK).  Each point 611 
represents a single animal with mean and standard deviation indicated.  Normal levels of 612 
circulating corticosteroid vary between ~150 – 600nM in an unstressed mouse and between 613 
1500-600nM in a stressed mouse (Barriga et al., 2001).  It should be noted that corticosteroid 614 
levels will increase in mice on handling which likely explains why serum levels in w/t mice 615 
are at the high end of normal. *Significantly different (P>95%) corticosteroid concentration 616 
versus C57Bl6 w/t mice using Student’s T test (two tailed). 617 
 618 
619 
 620 
 621 
622 
 623 
Fig. 6.  Phenotypic differences between the C57Bl6 w/t and Tg(Crh) mouse.  A, Appearance 624 
of female mice at 21 weeks of age, genotype as indicated.  Histology of skin (B), thymus (C) 625 
and spleen (D) after haematoxylin and eosin staining.  Tissues taken under the same 626 
magnification, demonstrating reduced thickness/size of all organs in Tg(Crh) mice.  E, RT-627 
PCR analysis for the expression of the indicated transcript, primer details as previously 628 
reported (Wallace et al., 2010a).  F, Pancreatic acinar cells were isolated from C57Bl6 w/t or 629 
C57Bl6 Tg(Crh) mice by collagenase digestion, fixed and stained for amylase and cyp2e1 as 630 
outlined (Wallace et al., 2010a).  Randomly selected fields were counted for amylase and/or 631 
cyp2e1 and the proportion of cells staining for either or both was determined (G). 632 
633 
 634 
Fig. 7.  The WNT signalling pathway.  Canonical WNT signalling is activated by a family of 635 
WNT proteins likely tethered to membranes by palmitoylation (Miura and Treisman, 2006) 636 
that interact with a receptor complex that includes frizzled proteins and low density 637 
lipoprotein receptor-related protein (LRP5/6).  The receptor complex leads to the 638 
phosphorylation of dishevelled within the cell that results in the phosphorylation and 639 
inactivation of the β-catenin destruction complex (which includes glycogen synthase kinase 3 640 
(GSK3β), axin, casein kinase 1 (CK1) and adenomatous polyposis coli (APC)).  The 641 
intracellular protein mediator therefore accumulates in the cell and when present in the 642 
nucleus, interacts with T cell factor/lymphoid enhancer factor (TCF) transcription factors that 643 
modulate gene expression including those related to stem cell plasticity such as oct 4, nanog 644 
(Cole et al., 2008) and Sox9 (Blache et al., 2004).  For more detailed review see Hoppler and 645 
Kavanagh (2007). 646 
 647 
648 
 649 
Fig. 8.  β-catenin localisation in C57Bl6 w/t and C57Bl6 Tg(Crh) pancreata and liver.  650 
Pancreata and liver were isolated from 21 week old female C57Bl6 w/t or C57Bl6 Tg(Crh) 651 
mice and fixed and stained with an antibody for β-catenin as outlined (Wallace et al., 2010a).  652 
Note, membrane localisation of β-catenin in pancreas from C57Bl6 w/t and more diffuse 653 
localisation in pancreas from C57Bl6 Tg(Crh) mouse. 654 
